We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

CMFT Healthcare associated infection (HCAI) Performance

Meticillin resistant Staphylococcus aureus (MRSA) bacteraemia and Clostridium difficile Infection

MRSA bloodstream infections (bacteraemia) can cause additional pain and suffering to patients and can delay the healing process. MRSA can enter the bloodstream from either a local site of infection (wound, abscess and ulcer), or following a healthcare intervention such as insertion of intravenous cannulae or urinary catheter. Below are the CMFT actual rates of infection compared to the set trajectory. 

Clostridium difficile infection (CDI) is a diagnosis in its own right. It covers a spectrum of disease from mild diarrohea to a severe condition. Older patients and those who have had a recent course of antibiotics are thought to be most at risk.  CMFT are committed to a 30% reduction in cases throughout the 2011/12 period.  Below are CMFT actual rates of infection compared with the trajectory set to achieve this reduction.

 

Month 2011-12

MRSA trajectory

MRSA bacteraemia CMFT

Clostridium difficile trajectory

Clostridium difficile CMFT

April

0

0

8

10

May

1

1

8

8

June

0

0

8

 

July 

1

 

8

 

August

0

 

8

 

September

1

 

8

 

October  

0

 

8

 

November

1

 

8

 

December

0

 

8

 

January

1

 

8

 

February

0

 

8

 

March

1

 

8